[Nivolumab in combination with ipilimumab - First-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma]
- PMID: 41067950
- DOI: 10.1016/j.bulcan.2025.07.021
[Nivolumab in combination with ipilimumab - First-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma]
Keywords: Advanced; Avancé; Cancer du foie; Carcinome hépatocellulaire (CHC); Hepatocellular carcinoma (HCC); Ipilimumab; Liver cancer; Nivolumab; Non résécable; Unresectable.
Conflict of interest statement
Déclaration de liens d’intérêts les auteurs déclarent ne pas avoir de liens d’intérêts.
Publication types
LinkOut - more resources
Full Text Sources
